{"assetProfile": {"address1": "Cheung Kong Center", "address2": "48th floor 2 Queen's Road Central", "city": "Hong Kong", "country": "Hong Kong", "phone": "852 2121 8200", "fax": "852 2128 1778", "website": "https://www.hutch-med.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. The company offers Fruquintinib, a selective and potent oral inhibitor of vascular endothelial growth factor receptors for treatment of colorectal cancer (CRC), breast cancer, gastric cancer (GC), microsatellite stable-CRC endometrial cancer (EMC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), endometrial cancer (EMC); and Savolitinib, a potent and selective inhibitor of mesenchymal-epithelial transition receptor to treat NSCLC, papillary RCC, and GC. It also develops Surufatinib to trea pancreatic neuroendocrine tumor (NET), non pancreatic NET, and pancreatic ductal adenocarcinoma; Sovleplenib, to treat immune thrombocytopenic purpura and warm autoimmune hemolytic anemia; and Tazemetostat, a treatment for epithelioid sarcoma and follicular lymphoma; Fanregratinib that treats intrahepatic cholangiocarcinoma; and Ranosidenib, a novel dual-inhibitor of dehydrogenase-1 and isocitrate dehydrogenase-2 enzymes to treat acute myeloid leukemia (AML). In addition, the company is developing HMPL-760, which is in phase I and II clinical trial to treat relapsed and/or refractory diffuse large B cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, and other B-NHL; HMPL-506 to treat Mixed-lineage leukemia-rearrange/rearrangement and nucleophosmin 1-mutantAML. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., and Epizyme, Inc., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.", "fullTimeEmployees": 1780, "companyOfficers": [{"maxAge": 1, "name": "Mr. Chig Fung  Cheng BEc, CA", "age": 57, "title": "Acting CEO, CFO & Executive Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": {"raw": 967439, "fmt": "967.44k", "longFmt": "967,439"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Wei-Guo  Su B.Sc., Ph.D.", "age": 66, "title": "CEO, Chief Scientific Officer & Executive Director (Leave of Absence)", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": {"raw": 2177384, "fmt": "2.18M", "longFmt": "2,177,384"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Edith  Shih BSE, C.S., CGP, EdM, FCIS, FCS, FCS(PE), M.A., P.E", "age": 72, "title": "Company Secretary & Non-Executive Director", "yearBorn": 1952, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yiling  Cui", "title": "Executive VP & Head of Operations", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "David  Ng", "title": "Head of Investor Relations & Capital Strategies", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Charles George Rupert  Nixon", "age": 54, "title": "Group General Counsel", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kin Hung  Lee M.B.A.", "age": 47, "title": "Senior Vice President of Corporate Management & Communications", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Selina  Zhang", "title": "Senior Vice President of Global Human Resources", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Qingmei  Wang Ph.D.", "age": 61, "title": "Executive Vice President of Business Development & Strategic Alliances", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Zhenping  Wu M.B.A, Ph.D.", "age": 65, "title": "Executive Vice President of Pharmaceutical Science & Manufacturing", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400}, "calendarEvents": {"maxAge": 1, "earnings": {"earningsDate": [{"raw": 1754539200, "fmt": "2025-08-07"}], "earningsCallDate": [{"raw": 1754568000, "fmt": "2025-08-07"}], "isEarningsDateEstimate": false, "earningsAverage": {}, "earningsLow": {}, "earningsHigh": {}, "revenueAverage": {}, "revenueLow": {}, "revenueHigh": {}}, "exDividendDate": {}, "dividendDate": {}}, "earningsTrend": {"trend": [{"maxAge": 1, "period": "0q", "endDate": null, "growth": {}, "earningsEstimate": {"avg": {}, "low": {}, "high": {}, "yearAgoEps": {}, "numberOfAnalysts": {}, "growth": {}, "earningsCurrency": null}, "revenueEstimate": {"avg": {"raw": 0, "fmt": null, "longFmt": "0"}, "low": {"raw": 0, "fmt": null, "longFmt": "0"}, "high": {"raw": 0, "fmt": null, "longFmt": "0"}, "numberOfAnalysts": {"raw": 0, "fmt": null, "longFmt": "0"}, "yearAgoRevenue": {}, "growth": {}, "revenueCurrency": null}, "epsTrend": {"current": {}, "7daysAgo": {}, "30daysAgo": {}, "60daysAgo": {}, "90daysAgo": {}, "epsTrendCurrency": null}, "epsRevisions": {"upLast7days": {}, "upLast30days": {}, "downLast30days": {}, "downLast7Days": {}, "downLast90days": {}, "epsRevisionsCurrency": null}}, {"maxAge": 1, "period": "+1q", "endDate": null, "growth": {}, "earningsEstimate": {"avg": {}, "low": {}, "high": {}, "yearAgoEps": {}, "numberOfAnalysts": {}, "growth": {}, "earningsCurrency": null}, "revenueEstimate": {"avg": {"raw": 0, "fmt": null, "longFmt": "0"}, "low": {"raw": 0, "fmt": null, "longFmt": "0"}, "high": {"raw": 0, "fmt": null, "longFmt": "0"}, "numberOfAnalysts": {"raw": 0, "fmt": null, "longFmt": "0"}, "yearAgoRevenue": {}, "growth": {}, "revenueCurrency": null}, "epsTrend": {"current": {}, "7daysAgo": {}, "30daysAgo": {}, "60daysAgo": {}, "90daysAgo": {}, "epsTrendCurrency": null}, "epsRevisions": {"upLast7days": {}, "upLast30days": {}, "downLast30days": {}, "downLast7Days": {}, "downLast90days": {}, "epsRevisionsCurrency": null}}, {"maxAge": 1, "period": "0y", "endDate": "2025-12-31", "growth": {"raw": 6.6684003, "fmt": "666.84%"}, "earningsEstimate": {"avg": {"raw": 1.68705, "fmt": "1.69"}, "low": {"raw": 0.48, "fmt": "0.48"}, "high": {"raw": 2.98, "fmt": "2.98"}, "yearAgoEps": {"raw": 0.22, "fmt": "0.22"}, "numberOfAnalysts": {"raw": 5, "fmt": "5", "longFmt": "5"}, "growth": {"raw": 6.6684003, "fmt": "666.84%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 593150870, "fmt": "593.15M", "longFmt": "593,150,870"}, "low": {"raw": 533400000, "fmt": "533.4M", "longFmt": "533,400,000"}, "high": {"raw": 667698000, "fmt": "667.7M", "longFmt": "667,698,000"}, "numberOfAnalysts": {"raw": 24, "fmt": "24", "longFmt": "24"}, "yearAgoRevenue": {"raw": 630201000, "fmt": "630.2M", "longFmt": "630,201,000"}, "growth": {"raw": -0.0588, "fmt": "-5.88%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": 1.68705, "fmt": "1.69"}, "7daysAgo": {"raw": 1.74705, "fmt": "1.75"}, "30daysAgo": {"raw": 1.74705, "fmt": "1.75"}, "60daysAgo": {"raw": 1.23258, "fmt": "1.23"}, "90daysAgo": {"raw": 0.86168, "fmt": "0.86"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 2, "fmt": "2", "longFmt": "2"}, "upLast30days": {"raw": 2, "fmt": "2", "longFmt": "2"}, "downLast30days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast7Days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "+1y", "endDate": "2026-12-31", "growth": {"raw": -0.6785, "fmt": "-67.85%"}, "earningsEstimate": {"avg": {"raw": 0.54245, "fmt": "0.54"}, "low": {"raw": 0.07, "fmt": "0.07"}, "high": {"raw": 1.13, "fmt": "1.13"}, "yearAgoEps": {"raw": 1.68705, "fmt": "1.69"}, "numberOfAnalysts": {"raw": 5, "fmt": "5", "longFmt": "5"}, "growth": {"raw": -0.6785, "fmt": "-67.85%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 701985730, "fmt": "701.99M", "longFmt": "701,985,730"}, "low": {"raw": 589999000, "fmt": "590M", "longFmt": "589,999,000"}, "high": {"raw": 849000000, "fmt": "849M", "longFmt": "849,000,000"}, "numberOfAnalysts": {"raw": 26, "fmt": "26", "longFmt": "26"}, "yearAgoRevenue": {"raw": 593150870, "fmt": "593.15M", "longFmt": "593,150,870"}, "growth": {"raw": 0.1835, "fmt": "18.35%"}, "revenueCurrency": "USD"}, "epsTrend": {"current": {"raw": 0.54245, "fmt": "0.54"}, "7daysAgo": {"raw": 0.69045, "fmt": "0.69"}, "30daysAgo": {"raw": 0.58362, "fmt": "0.58"}, "60daysAgo": {"raw": 0.69704, "fmt": "0.7"}, "90daysAgo": {"raw": 0.55722, "fmt": "0.56"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "upLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast7Days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}], "defaultMethodology": "nongaap", "maxAge": 1}, "earningsHistory": {"history": [], "defaultMethodology": "nongaap", "maxAge": 86400}, "financialData": {"maxAge": 86400, "currentPrice": {"raw": 15.31, "fmt": "15.31"}, "targetHighPrice": {"raw": 40.4, "fmt": "40.40"}, "targetLowPrice": {"raw": 6.4714, "fmt": "6.47"}, "targetMeanPrice": {"raw": 22.54343, "fmt": "22.54"}, "targetMedianPrice": {"raw": 21.26, "fmt": "21.26"}, "recommendationMean": {"raw": 1.69231, "fmt": "1.69"}, "recommendationKey": "buy", "numberOfAnalystOpinions": {"raw": 15, "fmt": "15", "longFmt": "15"}, "totalCash": {"raw": 1365645056, "fmt": "1.37B", "longFmt": "1,365,645,056"}, "totalCashPerShare": {"raw": 1.589, "fmt": "1.59"}, "ebitda": {"raw": -7491000, "fmt": "-7.49M", "longFmt": "-7,491,000"}, "totalDebt": {"raw": 100730000, "fmt": "100.73M", "longFmt": "100,730,000"}, "quickRatio": {"raw": 4.471, "fmt": "4.47"}, "currentRatio": {"raw": 4.651, "fmt": "4.65"}, "totalRevenue": {"raw": 602196992, "fmt": "602.2M", "longFmt": "602,196,992"}, "debtToEquity": {"raw": 8.111, "fmt": "8.11%"}, "revenuePerShare": {"raw": 3.52, "fmt": "3.52"}, "returnOnAssets": {"raw": -0.00811, "fmt": "-0.81%"}, "returnOnEquity": {"raw": 0.46897998, "fmt": "46.90%"}, "grossProfits": {"raw": 53762000, "fmt": "53.76M", "longFmt": "53,762,000"}, "freeCashflow": {"raw": -22782250, "fmt": "-22.78M", "longFmt": "-22,782,250"}, "operatingCashflow": {"raw": -32565000, "fmt": "-32.56M", "longFmt": "-32,565,000"}, "earningsGrowth": {"raw": 16.333, "fmt": "1,633.30%"}, "revenueGrowth": {"raw": -0.092, "fmt": "-9.20%"}, "grossMargins": {"raw": 0.08928, "fmt": "8.93%"}, "ebitdaMargins": {"raw": -0.01244, "fmt": "-1.24%"}, "operatingMargins": {"raw": -0.01265, "fmt": "-1.26%"}, "profitMargins": {"raw": 0.77529997, "fmt": "77.53%"}, "financialCurrency": "USD"}}